Reagent Kit for Glucose Determination Using the Glucose Oxidase Method in Serum, Plasma, and Urine (GLUCOSE DDS) According to TU 21.20.23.110-016-48813770-2016

This reagent kit is designed for the quantitative determination of glucose content in serum, plasma, and urine using the glucose oxidase method, in compliance with TU 21.20.23.110-016-48813770-2016.

Available Versions:

Version 1:

Reagent 1: Buffer-enzyme solution, pH 7.5
Calibrator: Glucose calibration solution, 5.55 mmol/L

Packaging Options:

Option 1: Reagent – 1 vial (100 ml), Calibrator – 1 vial (3.0 ml)
Option 2: Reagent – 6 vials (100 ml each), Calibrator – 2 vials (3.0 ml each)
Option 3: Reagent – 1 vial (1000 ml), Calibrator – 1 vial (10 ml)
Option 4: Reagent – 3 vials (68 ml each), Calibrator – 1 vial (3.0 ml)
Option 5: Reagent – 9 vials (68 ml each), Calibrator – 2 vials (3.0 ml each)
Option 6: Reagent – 3 vials (64 ml each), Calibrator – 1 vial (3.0 ml)
Option 7: Reagent – 9 vials (64 ml each), Calibrator – 1 vial (3.0 ml)
Option 8: Reagent – 3 vials (65 ml each), Calibrator – 1 vial (3.0 ml)
Option 9: Reagent – 9 vials (65 ml each), Calibrator – 1 vial (3.0 ml)
Option 10: Reagent – 6 vials (90 ml each), Calibrator – (details unspecified)

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Glucose Determination Using the Glucose Oxidase Method in Serum, Plasma, and Urine (GLUCOSE DDS) According to TU 21.20.23.110-016-48813770-2016, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Back